Baseline Utilization of Breast Radiotherapy Before Institution of the Medicare Practice Quality Reporting Initiative

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1506-1512

  Smith, Benjamin D ^a,b   Smith, Grace L ^b   Roberts, Kenneth B ^c   Buchholz, Thomas A ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast conserving therapy; Breast neoplasms; Pay for performance; Quality of care; Radiotherapy

Indexed keywords

BREAST CANCER; BREAST CONSERVING THERAPY; BREAST NEOPLASMS; BREAST RADIOTHERAPY; COMORBID ILLNESS; CONFIDENCE INTERVAL; CONSERVATIVE SURGERY; COVARIATES; DATA SETS; FINANCIAL INCENTIVES; GEOGRAPHIC REGIONS; MULTIVARIATE LOGISTIC REGRESSIONS; ODDS RATIOS; PAY-FOR-PERFORMANCE; POTENTIAL IMPACTS; QUALITY MEASURES; QUALITY OF CARE;

CHEMOTHERAPY; FORESTRY; PATIENT MONITORING; TUMORS;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT;

AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CLINICAL FEATURE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH CENTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICARE; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INSURANCE, PHYSICIAN SERVICES; LOGISTIC MODELS; MASTECTOMY, SEGMENTAL; MEDICARE; RADIOTHERAPY; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 67651102973     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.012     Document Type: Article

References (45)

1. Stulberg J. The physician quality reporting initiative-a gateway to pay for performance: What every health care professional should know. Qual Manag Health Care 17 (2008) 2-8
2. Centers for Medicare and Medicaid Services. Physician Quality Reporting Initiative. Available at: http://www.cms.hhs.gov/pqri/. Accessed July 20, 2008.
3. Rosenthal M.B., and Dudley R.A. Pay-for-performance: Will the latest payment trend improve care?. JAMA 297 (2007) 740-744
4. Doran T., Fullwood C., Gravelle H., et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 355 (2006) 375-384
5. Delaney G., Shafiq J., Chappell G., et al. Establishing treatment benchmarks for mammography-screened breast cancer population based on a review of evidence-based clinical guidelines. Cancer 112 (2008) 1912-1922
6. Nagel G., Rohrig B., Hoyer H., et al. [A population-based study on variations in the use of adjuvant radiotherapy in breast cancer patients]. Strahlenther Onkol 178 (2002) 589-596
7. Chung K.P., Lai M.S., Cheng S.H., et al. Organization-based performance measures of cancer care quality: Core measure development for breast cancer in Taiwan. Eur J Cancer Care (Engl) 17 (2008) 5-18
8. National Cancer Center. Surveillance, Epidemiology, and End Results. Available at: http://www.seer.cancer.gov. Accessioned July 20, 2008.
9. Du X., Freeman J.L., Warren J.L., et al. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care 38 (2000) 719-727
10. International classification of diseases. 9th revision, 3rd ed., clinical modification, volumes 1-3 (ICD-9-CM) (1991), Practice Management Information, Los Angeles
11. Buck C.J. 2002 ICD-9-CM, volumes 1-3 and HCPCS level II (2002), W.B. Saunders Company, Philadelphia (PA)
12. Kirschner C.G., Edwards N.K., May D.M., et al. Physicians' Current procedural terminology. 4th ed (1991), American Medical Association, Chicago
13. Anderson C.A., Beebe M., Dalton J.A., et al. Current procedural terminology-CPT 2002 (2002), American Medical Association, Chicago
14. Virnig B.A., Warren J.L., Cooper G.S., et al. Studying radiation therapy using SEER-Medicare-linked data. Med Care 40 (2002) IV-49-IV-54
15. Du X., Freeman J.L., and Goodwin J.S. Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol 52 (1999) 463-470
16. Warren J.L., Harlan L.C., Fahey A., et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40 (2002) IV-55-IV-61
17. Du X.L., Chan W., Giordano S., et al. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer 104 (2005) 913-924
18. Osborne C., Ostir G.V., Du X., et al. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat 93 (2005) 41-47
19. Keating N.L., Landrum M.B., Guadagnoli E., et al. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 24 (2006) 85-94
20. Bach P.B., Guadagnoli E., Schrag D., et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 40 (2002) IV-19-IV-25
21. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40 (1987) 373-383
22. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
23. Romano P.S., Roos L.L., and Jollis J.G. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 46 (1993) 1075-1079 discussion 1081-1090
24. Klabunde C.N., Potosky A.L., Legler J.M., et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 53 (2000) 1258-1267
25. Klabunde C.N., Warren J.L., and Legler J.M. Assessing comorbidity using claims data: An overview. Med Care 40 (2002) IV-26-IV-35
26. Fritz A., Percy C., Jack A., et al. International classification of diseases for oncology. 3rd ed (2000), World Health Organization, Geneva
27. Buchholz T.A., Theriault R.L., Niland J.C., et al. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol 24 (2006) 361-369
28. Carlson R.W., Anderson B.O., Burstein H.J., et al. Breast cancer. J Natl Compr Canc Netw 3 (2005) 238-289
29. Anderson B.O., Shyyan R., Eniu A., et al. Breast cancer in limited-resource countries: An overview of the Breast Health Global Initiative 2005 guidelines. Breast J 12 Suppl. 1 (2006) S3-S15
30. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 358 (2008) 213-216
31. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366 (2005) 2087-2106
32. Smith B.D., Haffty B.G., Hurria A., et al. Postmastectomy radiation and survival in older women with breast cancer. J Clin Oncol 24 (2006) 4901-4907
33. Smith B.D., Haffty B.G., Smith G.L., et al. Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys 71 (2008) 98-106
34. Vargas R.B., Ryan G.W., Jackson C.A., et al. Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer 113 (2008) 426-433
35. Vulto A.J., Lemmens V.E., Louwman M.W., et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002. Cancer 106 (2006) 2734-2742
36. Chagpar A.B., McMasters K.M., Scoggins C.R., et al. The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg 195 (2008) 793-798
37. Nattinger A.B., Hoffmann R.G., Kneusel R.T., et al. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356 (2000) 1148-1153
38. Malin J.L., Kahn K.L., Adams J., et al. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94 (2002) 835-844
39. Arthur D.W., and Vicini F.A. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 23 (2005) 1726-1735
40. Bickell N.A., Wang J.J., Oluwole S., et al. Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24 (2006) 1357-1362
41. Athas W.F., Adams-Cameron M., Hunt W.C., et al. Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92 (2000) 269-271
42. Voti L., Richardson L.C., Reis I.M., et al. Treatment of local breast carcinoma in Florida: The role of the distance to radiation therapy facilities. Cancer 106 (2006) 201-207
43. Hershman D.L., Buono D., McBride R.B., et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 100 (2008) 199-206
44. Pink G.H., Brown A.D., Studer M.L., et al. Pay-for-performance in publicly financed healthcare: Some international experience and considerations for Canada. Healthc Pap 6 (2006) 8-26
45. Gross C.P., Smith B.D., Wolf E., et al. Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?. Cancer 112 (2008) 900-908